Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Cancer Research Institute
Aug 17, 2024, 12:14 |
Dialogues
ASCO24 Updates: Is Combined Imaging the Key to Improved Myeloma Treatment?
The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the largest and most…
Aug 17, 2024, 09:04 |
Insight
Ralph DeBerardinis: Metabolism in human clear cell renal cell carcinoma
Ralph DeBerardinis, Chief of the Division of Pediatric Genetics and Metabolism at the Children’s Medical…
Aug 17, 2024, 08:50 |
Insight
Karl Semaan: Our study on first-line systemic therapy after adjuvant immunotherapy in RCC
Karl Semaan, Postdoctoral Oncology Research Fellow at Dana-Farber Cancer Institute, shared a post on X…
Aug 16, 2024, 19:53 |
Blog
Karen Knudsen: Home away from home for patients and caregivers
Karen Knudsen shared a post on LinkedIn: "Last night, I had the chance to spend…
Aug 16, 2024, 19:45 |
Insight
Jarushka Naidoo: SYK signature predicts irAEs from adjuv ICI in melanoma
Jarushka Naidoo shared a post on X: "SYK signature predicts irAEs from adjuv ICI in melanoma…
Aug 16, 2024, 15:47 |
Blog
Maite Bourlon: Leading Oncology Care with Compassion and Innovation
Maite Bourlon posted on X: "Thanks The Lancet for highlighting the work of oncology researchers…
Aug 16, 2024, 14:58 |
Blog
Ishwaria Subbiah about fighting burnout on Healthcare Unfiltered with Chadi Nabhan
Chadi Nabhan, Chief Medical Officer and Head of Strategy of Ryght, shared on X: "Can…
Aug 16, 2024, 14:16 |
Insight
Karl Semaan: First-line systemic therapy following adjuvant immunotherapy in renal cell carcinoma
Karl Semaan, Postdoctoral Research Fellow at Dana-Farber Cancer Institute, shared a post on X: “Just…
Aug 16, 2024, 14:13 |
Insight
OS rates for IMpower133 and IMbrella A extension study in SCLC
Biagio Ricciuti shared a paper by Martin Reck et al. on X, adding: “Five-year survival…
Aug 16, 2024, 12:43 |
Dialogues
Shubh Goel on Niagara Trial Results and AstraZeneca’s Global Impact
Shubh Goel, the VP and Head of Immuno-Oncology and GI Tumors at AstraZeneca, joins host…
183
184
185
186
187
All:
3144
Posts:
1841 - 1850
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube